Clinical Trials Directory

Trials / Completed

CompletedNCT01161992

Genomics of Primary Sclerosing Cholangitis (PSC)

P.R.O.G.R.E.S.S.: PSC Resource Of Genetic Risk, Environment and Synergy Studies.

Status
Completed
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
5 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done to investigate whether genes make people more likely to develop PSC. Discovery of these genes will help us to better understand how PSC developes and subsequently, to apply new approaches for its prevention, diagnosis and treatment.

Conditions

Interventions

TypeNameDescription
GENETICGenetic AnalysisPerform Genome Wide Association Studies.

Timeline

Start date
2002-03-01
Primary completion
2025-07-01
Completion
2025-07-31
First posted
2010-07-14
Last updated
2025-08-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01161992. Inclusion in this directory is not an endorsement.